HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $18,217 | -27.4% | 477 | +8.2% | 0.00% | -33.3% |
Q4 2022 | $25,093 | +47.6% | 441 | +0.2% | 0.00% | 0.0% |
Q3 2022 | $17,000 | -10.5% | 440 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $19,000 | +11.8% | 434 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $17,000 | 0.0% | 434 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $17,000 | +70.0% | 434 | +83.1% | 0.00% | +50.0% |
Q3 2021 | $10,000 | +150.0% | 237 | +189.0% | 0.00% | +100.0% |
Q2 2021 | $4,000 | -33.3% | 82 | -44.6% | 0.00% | -66.7% |
Q1 2021 | $6,000 | – | 148 | +7300.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 2 | -99.6% | 0.00% | -100.0% |
Q1 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |